Table 2

Age at the onset of VHL-related manifestations

ManifestationsMean±SDMedian (range)
CHB (59.1%)29.5±11.028.0 (10–66)
RA (19.9%)24.8±11.023.0 (2–55)
RCC (43.3%)36.4±10.934.0 (14–74)
PCL (40.6%)33.4±11.032.0 (10–66)
PHEO (13.4%)31.7±11.931.5 (8–66)
GS (6.5%)21.4±11.219.0 (4–56)
  • CHB, central nervous system haemangioblastoma; GS, genital system (epididymis or broad ligament); PCL, pancreatic cystic lesion; PHEO, pheochromocytoma; RA, retinal haemangioblastoma; RCC, renal cell carcinoma; VHL, von Hippel-Lindau.